Sign up to save your podcasts
Or
Share Stephanie Oestreich: Leadership across biotech and orchestras
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stephanie Oestreich: Leadership across biotech and orchestras
Stephanie Oestreich is Managing Director of the Myeloma Investment Fund (MIF), a venture philanthropy fund focused on therapies and technologies for multiple myeloma. She is the chair of the McCloy Alumni Association. She is also a faculty member at MIT, and an advisor at multiple drug development companies and healthcare investment companies.
Previously she worked as International Business Leader at Roche and Novartis. Then she also worked as CBO at Galecto, VP at Mnemo Therapeutics, a Venture Partner at RA Capital, and EVP at Evotec where she built its North American investment arm and started an incubator with Samsara BioCapital.
As a semi-professional violinist, she performs with Philharmonic orchestras in Carnegie Hall and other international venues and conducts workshops with live orchestras.
Stephanie conducted the research for her Ph.D. in biochemistry in the lab of Jack Szostak at Harvard Medical School and obtained an MPA from the Harvard Kennedy School.
In this episode,
* Stephanie shares about her upbringing in Germany and her early interest in science and medicine.
* She explains her motivation to pursue an MPA from Harvard Kennedy School to better understand drug approvals and funding decisions.
* She describes her transition from academia to biotech industry, highlighting her roles at Novartis as the CEO’s executive assistant and her involvement in various business development activities. She also discusses her move to Roche and details her global marketing role there.
* She credits her experience working in different regions across both Europe and the US and compares cultural differences in biotech across these regions.
* She talks about her leadership role in the MIF and introduces the mission of MIF within the Multiple Myeloma Research Foundation (MMRF).
* As a semi-professional violinist, she reflects the lessons that she learned from performing in symphony orchestras and how that translates to her work in biotech.
Co-Hosts: Yossef Baidi and Fang Xie
Planning: Yossef Baidi and Fang Xie
Post-Production: Yossef Baidi and Fang Xie
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit hbcpulse.substack.com
View all episodes
By Brought to you by the Harvard Biotech ClubStephanie Oestreich is Managing Director of the Myeloma Investment Fund (MIF), a venture philanthropy fund focused on therapies and technologies for multiple myeloma. She is the chair of the McCloy Alumni Association. She is also a faculty member at MIT, and an advisor at multiple drug development companies and healthcare investment companies.
Previously she worked as International Business Leader at Roche and Novartis. Then she also worked as CBO at Galecto, VP at Mnemo Therapeutics, a Venture Partner at RA Capital, and EVP at Evotec where she built its North American investment arm and started an incubator with Samsara BioCapital.
As a semi-professional violinist, she performs with Philharmonic orchestras in Carnegie Hall and other international venues and conducts workshops with live orchestras.
Stephanie conducted the research for her Ph.D. in biochemistry in the lab of Jack Szostak at Harvard Medical School and obtained an MPA from the Harvard Kennedy School.
In this episode,
* Stephanie shares about her upbringing in Germany and her early interest in science and medicine.
* She explains her motivation to pursue an MPA from Harvard Kennedy School to better understand drug approvals and funding decisions.
* She describes her transition from academia to biotech industry, highlighting her roles at Novartis as the CEO’s executive assistant and her involvement in various business development activities. She also discusses her move to Roche and details her global marketing role there.
* She credits her experience working in different regions across both Europe and the US and compares cultural differences in biotech across these regions.
* She talks about her leadership role in the MIF and introduces the mission of MIF within the Multiple Myeloma Research Foundation (MMRF).
* As a semi-professional violinist, she reflects the lessons that she learned from performing in symphony orchestras and how that translates to her work in biotech.
Co-Hosts: Yossef Baidi and Fang Xie
Planning: Yossef Baidi and Fang Xie
Post-Production: Yossef Baidi and Fang Xie
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit hbcpulse.substack.com